Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001095:Arachidonic Acids / Q000494:pharmacology*; D003994:Bucladesine / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism*; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D011464:Epoprostenol / Q000494:pharmacology; D005260:Female; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000378:metabolism; D011457:Prostaglandins D / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D001095:Arachidonic Acids; D011453:Prostaglandins; D011457:Prostaglandins D; D011458:Prostaglandins E; D012701:Serotonin; D000244:Adenosine Diphosphate; D003994:Bucladesine; D003094:Collagen; D013806:Theophylline; D011464:Epoprostenol; D000242:Cyclic AMP; D009638:Norepinephrine; D004837:Epinephrine